Taiju Utsugisawa

Adachi, 1238558, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells.

Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells.

Journal: Cancers
Published: May 27, 2023

Variant spectrum of PIEZO1 and KCNN4 in Japanese patients with dehydrated hereditary stomatocytosis.

Variant spectrum of PIEZO1 and KCNN4 in Japanese patients with dehydrated hereditary stomatocytosis.

Journal: Human genome variation
Published: September 12, 2022

Dyserythropoietic anaemia with an intronic GATA1 splicing mutation in patients suspected to have Diamond-Blackfan anaemia.

Dyserythropoietic anaemia with an intronic GATA1 splicing mutation in patients suspected to have Diamond-Blackfan anaemia.

Journal: EJHaem
Published: November 22, 2021

Enzymatic Changes in Red Blood Cells of Diamond-Blackfan Anemia.

Enzymatic Changes in Red Blood Cells of Diamond-Blackfan Anemia.

Journal: The Tohoku journal of experimental medicine
Published: September 16, 2021

Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1.

Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1.

Journal: Blood
Published: August 17, 2021

Preoperative autologous blood donation for kidney transplant and end-stage renal disease patients: A single-center study.

Preoperative autologous blood donation for kidney transplant and end-stage renal disease patients: A single-center study.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: September 11, 2020

Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.

Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.

Journal: International journal of clinical oncology
Published: July 31, 2020

Novel COL4A1 mutations identified in infants with congenital hemolytic anemia in association with brain malformations.

Novel COL4A1 mutations identified in infants with congenital hemolytic anemia in association with brain malformations.

Journal: Human genome variation
Published: July 31, 2020

Hereditary hemolytic anemia in newborns: clinical significance of genetic diagnosis

Hereditary hemolytic anemia in newborns: clinical significance of genetic diagnosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 09, 2020

KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.

KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.

Journal: Experimental hematology
Published: August 31, 2018

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.

Journal: PloS one
Published: October 17, 2016

ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia.

ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia.

Journal: Haematologica
Published: January 13, 2016
Showing 1-12 of 13

Last Updated: 09/26/2026